Authors are urged to introduce these corrections into any reprints they distribute. Secondary (abstract) services are urged to carry notice of these corrections as prominently as they carried the original abstracts.
The interactions between TNF␣ and the Adalimumab Fab listed in Table 2 and the references to these data in the text were incorrect. The corrected Table 2 and references to these data are provided.
PAGE 27062:
In the left column, the second sentence of the last paragraph should be as follows. "The Adalimumab epitope on TNF␣ is composed of a number of discontinuous segments, including residues TNF Pro-20, TNF -Gln-21, TNF Glu-23, TNF Lys-65 to TNF Gln-67, TNF Glu-110 to TNF Pro-113, TNF Tyr-141, and TNF Ala-145, to TNF Glu-146 and TNF Thr-72, TNF -His-73, TNF Thr-77, TNF Thr-79, TNF Ser-81, TNF Lys-90 to TNF Asn-92, and TNF Glu-135 to TNF Asn-137 of an adjacent TNF␣ protomer (Figs. 3 and 4) ."
PAGE 27063:
In the right column, " TNF Lys-72" in line four of the last paragraph should be " TNF Thr-72."
PAGE 27064:
In the left column, " TNF Pro-21" in the first line of the last paragraph should be " TNF Pro-20."
These corrections do not affect the interpretation of the results or the conclusions of this work. 
